Open AccessA randomized, double-blind trial of amorolfine 0.25% cream and sertaconazole 2% cream in limited dermatophytosis
Author(s) -
Amrita Sil,
Anirban Das,
Tushar Kanti Sarkar,
Arpita Sen,
Sriparna Chakravorty,
Manideepa SenGupta,
Anupam Das,
Somodyuti Chandra,
Santasmita Pal,
Debabrata Bandyopadhyay,
Nilay Kanti Das
Publication year - 2019
Publication title -
indian journal of dermatology venereology and leprology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.514
H-Index - 45
eISSN - 0973-3922
pISSN - 0378-6323
DOI - 10.4103/ijdvl.ijdvl_907_17
Subject(s) - medicine , adverse effect , dermatology , tinea capitis , erythema , randomized controlled trial , antifungal , clinical trial
Dermatophytosis is becoming increasingly unresponsive to conventional antifungals. Newer topical antifungals may be more effective in these patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom